R-alpha-lipoic acid (R-ALA)
R-Alpha Lipoic Acid (R-ALA / Na-R-ALA) · also known as Natural alpha-lipoic acid, Stabilized sodium R-lipoate, Na-R-ALA
R-ALA is an antioxidant, but the free form taken as a supplement is not the same as the cofactor bound to mitochondrial enzymes. Direct free-radical scavenging and AMPK activation have been seen mainly in in-vitro and animal studies. Higher total glutathione has been measured in humans, but the specific pathway has not been confirmed.
Clinical uses and human evidence
Peripheral neuropathy (numbness and tingling)
Body weight and body fat
High triglycerides
Blood sugar and insulin resistance
Studies (2)
- Jibril 2022 · Endocr Connect · Meta-analysis · n=1035 — Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized trials
- Luo 2025 · BMJ Open · Meta-analysis · n=704 — Alpha-lipoic acid on intermediate disease markers in overweight or obese adults: a systematic review and meta-analysis
All-cause mortality risk
Heart attack, stroke and other cardiovascular events
Mechanisms of action
Nrf2/ARE activation of endogenous antioxidant enzymes
In one human randomized controlled trial, R-ALA 600 mg/day raised HO-1 expression in peripheral blood mononuclear cells. That dose is higher than the 100–300 mg/day commonly used for this supplement, and there is currently no assurance that a lower dose would have the same effect.
Substrate and cofactor supply for glutathione (GSH) synthesis
In human trials, higher doses of racemic lipoic acid raised total blood glutathione, but the studies did not distinguish between synthesis, regeneration and transport. Cell studies show it can improve cystine utilization. The specific pathway has not been confirmed in humans, and the results should not be applied directly to usual doses of R-ALA.
AMPK sensing of cellular energy deficit and metabolic reprogramming
Animal and cell studies show that lipoic acid can increase AMPK activity and glucose uptake in skeletal muscle, and the GLUT4 translocation findings also come mainly from animal and cell studies. Human results on blood sugar or insulin sensitivity cannot substitute for direct measurement of AMPK phosphorylation in tissue, and the size of the effect at usual doses is unclear.
Direct free radical trapping and chemical quenching
Lipoic acid and its reduced form, dihydrolipoic acid, are redox-active in vitro and can react with free radicals. In the body, however, free lipoic acid is present only briefly and has to compete with other antioxidant systems, so its contribution to direct free-radical scavenging in humans is hard to determine.
Safety and drug interactions
Low blood sugar risk
Can improve insulin sensitivity. Reports link it to autoimmune hypoglycemia in East Asian people. Each of these may lower blood sugar. Taken together, especially on an empty stomach or alongside antidiabetic drugs, they may cause low blood sugar symptoms such as palpitations, shaking and cold sweats.